© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
September 05, 2008
In a secondary post-hoc analysis of the Reduction of Restenosis in Saphenous Vein Grafts with Cypher (RRISC) trial, we compared the long-term safety of sirolimus-eluting stents (SES) with bare-metal stents (BMS) in diseased saphenous vein grafts
Lawrence Eichenfield, MD: Phase 3 Trial Data on Ruxolitinib for Atopic Dermatitis
Karan Lal, DO: Relationship Between Psoriasis and the Skin, Gut Microbiome
Karan Lal, DO: Psoriasis Treatment Advances, Spesolimab for Generalized Pustular Psoriasis